Kathleen Mahoney, MD, PhD

Beth Israel Deaconess Medical Center

Academic Titles

Instructor, Medicine, Harvard Medical School

Research Program Affiliation

Member, Kidney Cancer

Member, Cancer Immunology

Research Abstract

At the Beth Israel Deaconess Medical Center. I have witnessed the clinical benefits that immune therapies (such as high dose interleukin 2, ipilimumab, and PD-1:PD-L1 blocking agents) can have in my patients. My current research focus in the laboratory is to better understanding the biology of immune checkpoints in tumors and how to augment patients’ immune response to effectively attack their tumors.